pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
368
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
lonigutamab
lonigutamab [INN]
Graves' Ophthalmopathy
$ALMS
ALUMIS INC.
0
catalysts
Marketed
lotilaner
Xdemvy (lotilaner)
Demodex Blepharitis
$TARS
Tarsus Pharmaceuticals, Inc.
0
catalysts
Phase 2
lufepirsen
Nexagon (lufepirsen [INN])
Persistent Corneal Epithelial Defects
Amber Ophthalmics Inc
0
catalysts
← prev
page 11 of 13
next →
131
Pain
89
Neurology
1
Marketed
mannitol
Bronchitol (mannitol)
Cystic Fibrosis
Arna Pharma Pty Ltd
0
catalysts
Marketed
moxifloxacin
Moxifloxacin (moxifloxacin [INN])
Bacterial Conjunctivitis
Fosun Pharma USA Inc
0
catalysts
Preclinical
nabilone
Glaucoma
Adtech Pharma Inc
0
catalysts
Marketed
natamycin
Natacyn (natamycin)
Blepharitis
$HROW
HARROW, INC.
0
catalysts
Marketed
nepafenac
Ilevro (nepafenac)
Ocular Inflammation
$HROW
HARROW, INC.
0
catalysts
Phase 2
nesvategrast
nesvategrast [INN]
Diabetic Macular Edema
OcuTerra Therapeutics Inc
0
catalysts
Marketed
netarsudil mesylate
Rhopressa (netarsudil mesylate)
Ocular Hypertension
$ALC
ALCON INC
0
catalysts
Phase 3
nintedanib
NINTEDANIB (nintedanib)
Pterygium
Platelet-derived growth factor receptor
Vascular endothelial growth factor receptor
Cloudbreak Therapeutics LLC
0
catalysts
Marketed
omidenepag isopropyl
Omlonti (omidenepag isopropyl)
Ocular Hypertension
Ocuvex Therapeutics Inc
0
catalysts
Marketed
onabotulinumtoxinA
Botox (onabotulinumtoxinA)
Lower Limb Muscle Spasticity
Allergan Sales LLC
0
catalysts
Preclinical
onabotulinumtoxinA biosimilar
Blepharospasm
$VTRS
Viatris Inc
0
catalysts
Phase 2
onzemipgene parvec
onzemipgene parvec [INN]
Dry (Atrophic) Macular Degeneration
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 2
oxymetazoline
oxymetazoline [INN]
Ptosis
Levation Pharma Ltd
0
catalysts
Phase 2
pacibekitug
Atherosclerosis
Interleukin-6
Tourmaline Bio Inc
0
catalysts
Marketed
perfluorohexyloctane
Miebo (perfluorohexyloctane)
Keratoconjunctivitis Sicca (Dry Eye)
$BLCO
Bausch & Lomb Corp
0
catalysts
Marketed
phentolamine mesylate
Ryzumvi (phentolamine mesylate)
Presbyopia
Adrenergic receptor alpha
$IRD
Opus Genetics, Inc.
0
catalysts
pre_registration
phentolamine mesylate + pilocarpine
Presbyopia
$VTRS
Viatris Inc
0
catalysts
Marketed
pimecrolimus
Pimecrolimus Oceanside (pimecrolimus)
Atopic Dermatitis (Atopic Eczema)
Bausch & Lomb Holdings Inc (Inactive)
0
catalysts
Phase 3
plasminogen concentrate
Conjunctivitis
Plasminogen
Plasma kallikrein
Kedrion SpA
0
catalysts
Phase 3
plastoquinone decyl triphenylphosphonium bromide
Visomitin
Keratoconjunctivitis Sicca (Dry Eye)
Mitotech SA
0
catalysts
Phase 3
polihexanide
Akantior (polihexanide)
Parasitic (Acanthamoeba) Corneal Ulcers
SIFI SpA
0
catalysts
Marketed
polymyxin B
Polymyxin B Sulfate (polymyxin B [INN])
Bacteremia
Xellia Pharmaceuticals USA LLC
0
catalysts
Phase 2
povidone iodine ER
povidone iodine [USP]
Bacterial Conjunctivitis
iView Therapeutics Inc
0
catalysts
Marketed
prednisolone
Prednisolone (prednisolone [INN])
Allergic Conjunctivitis
Teva Pharmaceuticals USA Inc
0
catalysts
Marketed
prednisolone sodium phosphate
Prednisolone Sodium Phosphate (prednisolone sodium phosphate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Mission Pharmacal Co
0
catalysts
Marketed
prednisone
Prednisone (prednisone [INN])
Aspiration Pneumonitis
Vintage Pharmaceuticals Inc (Inactive)
0
catalysts
Phase 2
privosegtor
privosegtor [INN]
Non-Arteritic Anterior Ischemic Optic Neuropathy
$OCS
Oculis Holding AG
0
catalysts
